Serum albumin was negatively associated with diabetic peripheral neuropathy in Chinese population: a cross-sectional study
Open Access
- 15 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 13 (1), 1-9
- https://doi.org/10.1186/s13098-021-00718-4
Abstract
Previous studies that explored the relationship of serum albumin with diabetic peripheral neuropathy (DPN) have indicated inconsistent results. Thus, the present study aimed to evaluated the association between serum albumin and DPN, defined as vibration perception threshold (VPT) values ≥ 25 V and/or inability to feel the monofilament, in Chinese patients with type 2 diabetes mellitus (T2DM). 1465 T2DM patients aged ≥ 16 years, who completed the measurement of serum albumin and DPN screening between 2012 and 2015, were included in the cross-sectional study. Correlation and multivariate logistic regression analysis models were used to evaluate the possible relationship between serum albumin and DPN. Patients with higher quartiles of serum albumin had significantly lower VPT values and prevalence of DPN compared with those with lower quartiles (P for trend < 0.01), and there was an inverse relationship between serum albumin and VPT values and prevalence of DPN (all P < 0.01). Multivariate logistic regression analysis demonstrated that the risk of DPN was progressively decreased across serum albumin quartiles (P for trend < 0.01), and participants in the highest quartile of serum albumin were at a significantly decreased risk of DPN compared to those in the lowest quartile (odds rate: 0.311, 95% confidence intervals 0.134–0.724, P < 0.01). ROC analysis revealed that the optimal cutoff point of serum albumin for the prevalence of DPN was 39.95 g/L in patients with T2DM, with a sensitivity of 65.88% and a specificity of 66.7%. Decreased levels of serum albumin might be correlated with increased risk of DPN in Chinese patients with T2DM. Future longitudinal studies with large samples are warranted to confirm our findings, and elucidate putative mechanisms for the association.Keywords
Funding Information
- grants from the Ministry Science and Technology of China (2016YFC0901200, 2016YFC0901205)
- research grants from Health and Family Planning Commission of Sichuan Province (16129)
This publication has 41 references indexed in Scilit:
- Current perspectives on potential role of albumin in neuroprotectionProgress in Neurobiology, 2011
- Diabetic nephropathyDiabetology & Metabolic Syndrome, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metforminClinical Science, 2008
- Ambulatory Blood Pressure and Heart Rate in Hypertensives with Renal Failure: Comparison between Diabetic Nephropathy and Non-Diabetic GlomerulopathyClinical and Experimental Hypertension, 2008
- Serum albumin improves recovery from spinal cord injuryJournal of Neuroscience Research, 2007
- A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery diseaseThrombosis and Haemostasis, 2004
- Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis – interrelation with traditional cardiovascular risk factorsThrombosis and Haemostasis, 2004
- Albumin selectively inhibits TNFα-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cellsCardiovascular Research, 2002
- Human Albumin Therapy of Acute Ischemic StrokeStroke, 2001